Global Press Releases
Navigate within 'Global Press Releases'
Sandoz receives approval for first-ever Japanese biosimilar
Holzkirchen, June 25, 2009
Sandoz receives approval for first-ever Japanese biosimilar, recombinant human growth hormone
Latest News
Basel, May 20, 2009
Sandoz to acquire EBEWE Pharma specialty generics business, improving access for patients worldwide to injectable cancer drugs.
Latest results - Q1 2009
Basel, April 23, 2009
Pharmaceuticals delivers strong underlying growth in first quarter of 2009 as Novartis continues to rejuvenate product portfolio.
Sandoz and Novartis in the fight against tuberculosis
Holzkirchen, March 19, 2009
The war against tuberculosis has been fought for well over a century yet it continues to claim nearly two million victims per year – or one person every 15 seconds. Given that horrific figure, global awareness of this killer disease remains astonishingly low.
Sandoz receives European Commission approval for biosimilar filgrastim
Holzkirchen, February 13, 2009
Sandoz receives approval for its third biosimilar medicine, further reinforcing pioneer position in field
Sandoz fully cooperating with European Commission investigation of the pharmaceuticals industry
Holzkirchen, January 16, 2008
Sandoz, the generics division of Novartis, announced today that it was fully cooperating with the European Commission in its investigation of the pharmaceuticals industry.
Sandoz and Gambro form strategic alliance
Holzkirchen, Germany, January 08, 2008
Cooperation in the launch of biosimilar Binocrit® into selected European markets. Joining forces in the area of hemodialysis to increase opportunities for treatment of chronic kidney disease.
